Stephanie Davis
Nurse Practitioner · Casper, WYNPI 1972051423
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 83.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $252 and has fallen 83.2% since, to $42 in 2025.
Across 32 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$606
- Edwards Lifesciences$62
- AstraZeneca$18
- Philips North America LLC$16
- E.r. Squibb & Sons, L.L.C.$15
- Medtronic$13
What the payments were for
- Food & beverage$730100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 25 | $606 |
| Edwards Lifesciences | 3 | $62 |
| AstraZeneca | 1 | $18 |
| Philips North America LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Medtronic | 1 | $13 |
How this compares
$730 in reported general payments places this provider in the 85th percentile of 150 nurse practitioner providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 82 | $84,997 |
| EntrestoSacubitril/Valsartan | 23 | $19,424 |
| Repatha SureclickEvolocumab | 14 | $10,121 |
| Atorvastatin Calcium | 117 | $1,149 |
| Carvedilol | 101 | $1,130 |
| ClopidogrelClopidogrel Bisulfate | 99 | $990 |
| Metoprolol Succinate | 84 | $920 |
| Potassium Chloride | 43 | $746 |
| Rosuvastatin Calcium | 49 | $678 |
| Amlodipine Besylate | 74 | $468 |
| Flecainide Acetate | 16 | $406 |
| Losartan Potassium | 43 | $364 |
| Furosemide | 69 | $350 |
| Pantoprazole Sodium | 24 | $324 |
| Metoprolol Tartrate | 82 | $314 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Casper
- Kristin BrittCasper$5K
- Kerry FischerCasper$4K
- Molly RodrickCasper$3K
- Janine GloverCasper$3K
- Amy GruwellCasper$3K
- Jamie KidderCasper$3K
- Aaron RutzCasper$2K
- Brandon BennionCasper$2K
- Sarah PeakCasper$507
- Julie NovickCasper$481
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.